Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veal

Showing results (411-420 of 651) with videos related to

Pageof 66
Sort By:
Drugs & Aging|May 5, 2023
Identifying Residents Who May Benefit from an Analgesic Review: Applying Analgesic Indicators in Residential Aged Care ServicesLaura A Dowd, Amanda J Cross, Shin J Liau, et al.
The British Journal of Dermatology|June 14, 2005
Functional MASP2 single nucleotide polymorphism plays no role in psoriasisC Stover, S Barrett, N J Lynch, et al.
AIDS (London, England)|August 1, 1994
Zidovudine phosphorylation in HIV-infected patients and seronegative volunteersM Barry, M Wild, G Veal, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 6, 2023
Physiologically-based pharmacokinetic model to predict doxorubicin and paclitaxel exposure in infants through breast milkDavid Damoiseaux, Frédéric Amant, Jos H Beijnen, et al.
Journal of Medicinal Chemistry|August 16, 2011
Synthesis and biological evaluation of 3-(1H-imidazol- and triazol-1-yl)-2,2-dimethyl-3-[4-(naphthalen-2-ylamino)phenyl]propyl derivatives as small molecule inhibitors of retinoic acid 4-hydroxylase (CYP26)Mohamed S Gomaa, Caroline E Bridgens, Gareth J Veal, et al.
Cancer Chemotherapy and Pharmacology|August 25, 2009
Pharmacokinetics of carboplatin and etoposide in infant neuroblastoma patientsGareth J Veal, Michael Cole, Julie Errington, et al.
Oncology Research|March 16, 2010
Targeting of multiple signaling pathways by the Hsp90 inhibitor SNX-2112 in EGFR resistance models as a single agent or in combination with erlotinibJohn W Rice, James M Veal, Amy Barabasz, et al.
British Journal of Cancer|January 17, 2007
Pharmacokinetics and metabolism of 13-cis-retinoic acid (isotretinoin) in children with high-risk neuroblastoma - a study of the United Kingdom Children's Cancer Study GroupG J Veal, M Cole, J Errington, et al.
Journal of Applied Gerontology : the Official Journal of the Southern Gerontological Society|March 28, 2022
Feasibility and Acceptability of a Group Music Intervention in Memory Care CommunitiesBritney M Veal, Debra Dobbs, Soomi Lee, et al.
European Journal of Cancer (Oxford, England : 1990)|June 30, 2012
Busulfan pharmacokinetics following intravenous and oral dosing regimens in children receiving high-dose myeloablative chemotherapy for high-risk neuroblastoma as part of the HR-NBL-1/SIOPEN trialG J Veal, L Nguyen, A Paci, et al.
Pageof 66

Showing results (411-420 of 651) with videos related to

Sort By:
Pageof 66
Drugs & Aging|May 5, 2023
Identifying Residents Who May Benefit from an Analgesic Review: Applying Analgesic Indicators in Residential Aged Care ServicesLaura A Dowd, Amanda J Cross, Shin J Liau, et al.
The British Journal of Dermatology|June 14, 2005
Functional MASP2 single nucleotide polymorphism plays no role in psoriasisC Stover, S Barrett, N J Lynch, et al.
AIDS (London, England)|August 1, 1994
Zidovudine phosphorylation in HIV-infected patients and seronegative volunteersM Barry, M Wild, G Veal, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 6, 2023
Physiologically-based pharmacokinetic model to predict doxorubicin and paclitaxel exposure in infants through breast milkDavid Damoiseaux, Frédéric Amant, Jos H Beijnen, et al.
Journal of Medicinal Chemistry|August 16, 2011
Synthesis and biological evaluation of 3-(1H-imidazol- and triazol-1-yl)-2,2-dimethyl-3-[4-(naphthalen-2-ylamino)phenyl]propyl derivatives as small molecule inhibitors of retinoic acid 4-hydroxylase (CYP26)Mohamed S Gomaa, Caroline E Bridgens, Gareth J Veal, et al.
Cancer Chemotherapy and Pharmacology|August 25, 2009
Pharmacokinetics of carboplatin and etoposide in infant neuroblastoma patientsGareth J Veal, Michael Cole, Julie Errington, et al.
Oncology Research|March 16, 2010
Targeting of multiple signaling pathways by the Hsp90 inhibitor SNX-2112 in EGFR resistance models as a single agent or in combination with erlotinibJohn W Rice, James M Veal, Amy Barabasz, et al.
British Journal of Cancer|January 17, 2007
Pharmacokinetics and metabolism of 13-cis-retinoic acid (isotretinoin) in children with high-risk neuroblastoma - a study of the United Kingdom Children's Cancer Study GroupG J Veal, M Cole, J Errington, et al.
Journal of Applied Gerontology : the Official Journal of the Southern Gerontological Society|March 28, 2022
Feasibility and Acceptability of a Group Music Intervention in Memory Care CommunitiesBritney M Veal, Debra Dobbs, Soomi Lee, et al.
European Journal of Cancer (Oxford, England : 1990)|June 30, 2012
Busulfan pharmacokinetics following intravenous and oral dosing regimens in children receiving high-dose myeloablative chemotherapy for high-risk neuroblastoma as part of the HR-NBL-1/SIOPEN trialG J Veal, L Nguyen, A Paci, et al.
Pageof 66